Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes

Summary

The purpose of this clinical Study is TJCS Eye Drops 0.05%(Cyclosporine ophthalmic nano-emulsion) group and Restasis Eye Drops 0.05%(Cyclosporine ophthalmic suspension) group 12 weeks after treatment, each treatment group comparisons for evaluation of efficacy and safety in Moderate to Severe Dry Eye Disease.

Timeline

Start

2014-01

Primary completion

2014-09

Completion

2014-10

Drugs

Indications